Malign Pleural Effusion In A Patient With Multiple Myeloma,

Öz

Anahtar Kelimeler

• -

Malign Pleural Effusion In A Patient With Multiple Myeloma,

Öz

Malign plevral effüzyon, multiple myelomda progresyonla karekterize ve geç gelişen bir komplikasyondur. Tanıdan sonra ortalama yaşam süresi 4 aydır ve sistemik kemoterapilere oldukça dirençlidir. Biz bu makalede 49 yaşında tanıdan 4 ay sonra malign plevral effüzyon gelişen ve solunum yetmezliği nedeniyle kaybedilen bir hastayı sunuyoruz

Anahtar Kelimeler

• Multiple myelom, plevral effüzyon

Kaynakça

1. Kyle RA, Rajkumar SV. Multiple myeloma; in Goldman L, Ausiello DA (eds): Cecil Textbook of Medicine, ed 22. Philadelphia, Saunders, 2004;1184–1195.
2. John CH, May LV. Pleural effusion in multiple myeloma. Cancer 1979;44: 1150-1154.
3. Meoli A, Willsie S, Fiorella R. Myelomatous pleural effusion. South Med J 1997; 90: 65–68.
4. Palmer HE, Wilson CS, Bardales RH. Cytology and flow cytometry of malignant effusions of multiple myeloma. Diagn Cytopathol 2000; 22: 147–151.
5. Alexandrakis MG, Passam FH, Kyriakou DS and Bouros D. Pleural effusions in hematologic malignancies. Chest 2004;125:1546 – 1555.
6. VSS Attili, VP Singh, S Sundar, et al. Malignant myelomatous pleural effusion with good response to combination chemotherapy. J Assoc Physicians India. 2007;55:595-596.
7. Abbate SL, Jaff MR, Fishleder AJ, et al. Lambda light chain myeloma with pleural involvement. Cleve Clin Med 1991;58:235-239.
8. Kim YJ, Kim SJ, Min K, et al. Multiple Myeloma with Myelomatous Pleural Effusion: A Case Report and Review of the Literature. Acta Haematol 2008;120:108–111.

9. Gogia A, Agarwal PK, Jain S, Jain KP. Myelomatous Pleural Effusion. J Assoc Physicians India 2005;53:734-736.
10. Kamble R, Wilson CS, Fassas A. Malignant pleural effusion of myeloma: Prognostic factors and outcome. Leuk Lymph 2005;46:1137-1142.